“Innovative Immunotherapy Developed for Treating Brain Cancer”
Groundbreaking Immune Therapy Shows Promise for Glioblastoma Treatment A research team led by Dr. David B. Weiner, Executive Vice President of The Wistar Institute and director of its Vaccine & Immunotherapy Center, has achieved a major milestone in glioblastoma research. Known as the deadliest form of brain cancer, glioblastoma has a grim survival rate of…